Ten cases of chronic myeloproliferative diseases with myelofibrosis and circulating megakaryoblasts have been studied. The megakaryoblasts were recognized by the presence of megakaryocyte-platelet-related cell surface antigens, detected by an immuno-electron-microscopic method. They showed a tendency to develop from ‘lymphocyte-like’ mononuclear cells to relatively mature megakaryocytes. In these latter cells, the cytoplasm was abundant and contained specific organelles and cytoplasmic blebs. Several characteristic features were observed during the maturation of the megakaryoblasts: (1) cells of the megakaryocytic lineage represented by microforms, (2) dysplastic platelets (giant, nucleated and agranular platelets), (3) the shedding of dysplastic platelets brought about by cytoplasmatic membrane inclusions and (4) naked nuclei.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.